The transmembrane proteoglycan CSPG4 had been originally identified by Dr Ferrone‘s team as a highly immunogenic tumor antigen on the surface of melanoma cells and was named High Molecular Weight Melanoma-Associated Antigen [51]. Here, CSPG4 is linked to melanoma.